Search research articles
Contact Us
Filters
Showing results (1-10 of 174) with videos related to
Page
of 18
Sort By:
Free Radical Biology & Medicine
|
January 16, 2008
Poly(ADP-ribose) polymerase inhibition as a novel therapeutic approach against intraepidermal nerve fiber loss and neuropathic pain associated with advanced diabetic neuropathy: a commentary on "PARP Inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy"
Pal Pacher
Proceedings of the National Academy of Sciences of the United States of America
|
June 8, 2021
Cyanide emerges as an endogenous mammalian gasotransmitter
Pal Pacher
Current Drug Targets
|
December 4, 2014
The activated endocannabinoid system in atherosclerosis: driving force or protective mechanism?
Sabine Steffens, Pal Pacher
Circulation
|
April 10, 2002
Use of selective serotonin reuptake inhibitors and myocardial infarction
Pal Pacher, Zoltan Ungvari
Science Translational Medicine
|
August 10, 2012
The outsiders: emerging roles of ectonucleotidases in inflammation
Csaba Szabo, Pal Pacher
Current Medicinal Chemistry
|
April 14, 2004
Trends in the development of new antidepressants. Is there a light at the end of the tunnel?
Pal Pacher, Valeria Kecskemeti
Current Pharmaceutical Design
|
August 24, 2004
Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?
Pal Pacher, Valeria Kecskemeti
The American Journal of Pathology
|
June 7, 2008
Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease
Pal Pacher, Csaba Szabo
JACC. Cardiovascular Imaging
|
October 23, 2017
Psoriasis-Related Visceral Adiposity and Arterial Inflammation: A New Adiposity Disease Entity?
Thomas H Schindler, Pal Pacher
Heart Failure Reviews
|
January 9, 2014
Pathophysiological mechanisms of catecholamine and cocaine-mediated cardiotoxicity
Lucas Liaudet, Belinda Calderari, Pal Pacher
Page
of 18
Search research articles
Search
Showing results (1-10 of 174) with videos related to
Sort By:
Page
of 18
Free Radical Biology & Medicine
|
January 16, 2008
Poly(ADP-ribose) polymerase inhibition as a novel therapeutic approach against intraepidermal nerve fiber loss and neuropathic pain associated with advanced diabetic neuropathy: a commentary on "PARP Inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy"
Pal Pacher
Proceedings of the National Academy of Sciences of the United States of America
|
June 8, 2021
Cyanide emerges as an endogenous mammalian gasotransmitter
Pal Pacher
Current Drug Targets
|
December 4, 2014
The activated endocannabinoid system in atherosclerosis: driving force or protective mechanism?
Sabine Steffens, Pal Pacher
Circulation
|
April 10, 2002
Use of selective serotonin reuptake inhibitors and myocardial infarction
Pal Pacher, Zoltan Ungvari
Science Translational Medicine
|
August 10, 2012
The outsiders: emerging roles of ectonucleotidases in inflammation
Csaba Szabo, Pal Pacher
Current Medicinal Chemistry
|
April 14, 2004
Trends in the development of new antidepressants. Is there a light at the end of the tunnel?
Pal Pacher, Valeria Kecskemeti
Current Pharmaceutical Design
|
August 24, 2004
Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?
Pal Pacher, Valeria Kecskemeti
The American Journal of Pathology
|
June 7, 2008
Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease
Pal Pacher, Csaba Szabo
JACC. Cardiovascular Imaging
|
October 23, 2017
Psoriasis-Related Visceral Adiposity and Arterial Inflammation: A New Adiposity Disease Entity?
Thomas H Schindler, Pal Pacher
Heart Failure Reviews
|
January 9, 2014
Pathophysiological mechanisms of catecholamine and cocaine-mediated cardiotoxicity
Lucas Liaudet, Belinda Calderari, Pal Pacher
Page
of 18